ERS GenomicsJun28New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurgeby ERS Genomics | June 28, 2022190Dublin, Ireland | ERS Genomics Limited [1] (‘ERS’) is pleased to announce a new license agreement with Cytosurge AG [2] (‘Cytosurge‘). This is a non-exclusive licensing agreement granting Cytosurge ac... Read more > Press ReleaseCorporateFluidFM ApplicationsJun 28, 2022Press Release
Claudia FreyJun27The start-ups taking nanoneedles into the clinicby Claudia Frey | June 27, 202272Nature Nanotechnology | Nanoneedle start-ups are traversing the biotech valley of death — from fundamental university research into commercial development in advanced therapeutics and diagnostics. How... Read more > Press ClippingCorporateJun 27, 2022Press Clipping
Stony Brook University (SUNY)Jun22Research Centered on Single Cells May Open Doors to New Discoveries on Disease Processesby Stony Brook University (SUNY) | June 22, 2022148Stony Brook, NY | Gábor Balázsi [1] , PhD, and his research team in the Laufer Center [2] and the Department of Biomedical Engineering [3] at Stony Brook University are embarking upon a new way to res... Read more > Press ReleaseCorporateFluidFM ApplicationsJun 22, 2022Press Release
Claudia FreyMar30Cytosurge launches cell line engineering services based on proprietary FluidFM® technologyby Claudia Frey | March 30, 2022435Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for gene... Read more > Press ReleaseCorporateFluidFM ApplicationsMar 30, 2022Press Release
Claudia FreyMar07Multiplexing Speeds up Writing and Editing DNAby Claudia Frey | March 7, 202250Labiotech.eu | While scientists can read DNA fast, editing and writing it is not that easy. Increasing the speed of editing and writing DNA sequences will be critical to ushering in new application... Read more > Press ClippingMar 7, 2022Press Clipping
Claudia FreyJan18R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisseby Claudia Frey | January 18, 2022402Zurich | Cytosurge [1] , a leading global provider for precision single cell manipulation, is delighted to announce that together with the Laboratory of Biosensors and Bioelectronics (LBB) [2] at the ... Read more > Press ReleaseCorporateFluidFM ApplicationsJan 18, 2022Press Release
Katarina SvitekJan03Mitochondria transplantation with FluidFMby Katarina Svitek | January 3, 2022439Today, we are happy to introduce you to Christoph Gäbelein who developed a FluidFM-based approach to extract, inject and transplant organelles from and into living cells with subcellular spatial resol... Read more > Company BlogFluidFM ApplicationsJan 3, 2022Company Blog
Claudia FreyDec22Season's Greetings & Highlights in 2021by Claudia Frey | December 22, 2021501The past year has been a year of successful transformation and growth for us, even in these difficult times. Without your support and the great work of our employees, this would not have been possible... Read more > Company BlogCompany LifeCorporateDec 22, 2021Company Blog
Claudia FreyAug04Partnership between Central Scientific Commerce and Cytosurgeby Claudia Frey | August 4, 2021911Zurich | We are delighted to announce our collaboration with CSC, a well-established and renowned Japanese organization specialized in the distribution of systems for life science research. Within thi... Read more > Press ReleaseCorporateAug 4, 2021Press Release
Claudia FreyMar24Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeksby Claudia Frey | March 24, 2021830Zurich | Cytosurge [1] , a leading global provider for precision single cell manipulation [2] , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate... Read more > Press ReleaseCorporateFluidFM ApplicationsMar 24, 2021Press Release
Paul MonnierMar08FluidFM: A new approach to CRISPR gene editingby Paul Monnier | March 8, 20212189With traditional delivery methods, such as lipofection or electroporation, the success of CRISPR-Cas mediated gene editing is often subpar due to poor cell viability and low transfection efficiency ra... Read more > Company BlogFluidFM ApplicationsMar 8, 2021Company Blog
Claudia FreyJan27Partnership between RAMCON & Cytosurgeby Claudia Frey | January 27, 2021710Zurich | We are delighted to announce that RAMCON has been appointed as distributor in the Nordic Countries. RAMCON will distribute our FluidFM BIO Series lab solutions that enable cutting-edge experi... Read more > Press ReleaseCorporateJan 27, 2021Press Release
